[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349503-105":59,"doc-detail-349503-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","distinct-epigenetic-alterations-and-accelerated-mitotic-aging-define-second-primary-breast-cancers","Distinct epigenetic alterations and accelerated mitotic aging define second primary breast cancers","","Second primary breast cancers (SPBCs) increasingly affect cancer survivors, yet their biological drivers remain poorly understood compared with first primary breast cancers (FPBCs). Genome-wide DNA methylation profiling of paired ER-positive, HER2-negative tumors (SPBC n=13, FPBC n=29) plus validation using The Cancer Genome Atlas integrates genomic, transcriptomic, proteomic, and epigenomic data. SPBC tumors show poorer prognosis, 11,321 differentially methylated CpGs, altered TFBS methylation, and significantly elevated mitotic age, with suppressed endocrine signaling and evidence of recurrent molecular scars.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/distinct-epigenetic-alterations-and-accelerated-mitotic-aging-define-second-primary-breast-cancers/349503/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/distinct-epigenetic-alterations-and-accelerated-mitotic-aging-define-second-primary-breast-cancers/349503.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What distinguishes SPBCs from FPBCs at the molecular level in this study?","Question",{"text":112,"@type":113},"SPBC tumors show poorer prognosis and recurrent epigenetic “molecular scars,” including suppressed endocrine signaling and accelerated mitotic aging. The study identifies many differentially methylated CpG sites and altered methylation at transcription factor binding sites tied to aging and malignancy traits.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were epigenetic alterations and aging measured in the research?",{"text":117,"@type":113},"DNA methylation profiling was used to detect differential CpG sites between SPBC and FPBC. Epigenetic aging was assessed using the mitotic clock epiTOC, while ENCODE chromatin immunoprecipitation sequencing data mapped changes at transcription factor binding sites.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the evidence that epigenetic changes relate to hormone signaling in SPBC?",{"text":121,"@type":113},"Transcriptomic analysis confirmed coordinated downregulation of hormone signaling pathways, including estrogen, progesterone, and androgen cascades. This aligns with promoter-level hypermethylation enriched in genes involved in morphogenesis, hormone signaling, and cell adhesion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349503,1790194015,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDistinct epigenetic alterations and accelerated mitotic aging define second primary breast cancers  \nAndrés F. Bedoya-López1,8, Javier I. J. Orozco2,3,8, Pere Llinàs-Arias1,  \nMiquel Ensenyat-Mendez4, Betsy J. Valdez2, Sandra Iñiguez-Muñoz1, Mar Morote-Llabrés1, Chikako Matsuba5,6, Matthew P. Salomon6, Diego M. Marzese1,4,7􀀍 &  \nMelanie Goldfarb2􀀍  \nAs cancer survivorship is steadily increasing, second primary breast cancers (SPBCs) are becoming amore common disease linked to poorer clinical outcomes compared to first primary breast cancers (FPBCs). While the molecular features of FPBCs are well characterized, the biological drivers of SPBCs remain largely unexplored. We performed genome-wide DNA methylation profiling and analysis of clinically and demographically paired ER-positive, HER2-negative SPBC (n = 13) and FPBC (n = 29) . We validated our findings by integrating genomic, transcriptomic, proteomic, and epigenomic data from paired tumors from The Cancer Genome Atlas. Chromatin Immunoprecipitation sequencing maps from ENCODE were used to examine epigenetic alterations of transcription factor binding sites (TFBSs) linked to accelerated aging and malignancy traits in SPBC. Epigenetic aging was assessed using the mitotic clock epiTOC. Here, we show that SPBC tumors are associated with poorer prognosis compared to FPBC. Epigenetic profiling identified 11,321 differentially methylated CpG sites compared to FPBCs, with hypermethylation enriched at gene promoters involved in morphogenesis, hormone signaling, and cell adhesion processes. Concordantly, transcriptomic analysis confirmed a coordinated downregulation of hormone signaling pathways, including estrogen, progesterone, and androgen cascades. Beyond promoter-level changes, SPBC tumors exhibit altered DNA methylation at key TFBSs involved in accelerated aging and cancer traits and significantly elevated mitotic age. SPBC tumors exhibit recurrent molecular scars, defined by suppressed endocrine signaling and accelerated mitotic aging. These epigenetic hallmarks may reflect the cumulative effects associated with prior malignancy and its clinical context, potentially contributing to more aggressive disease behavior. Our findings provide a foundation for developing personalized risk stratification and therapeutic approaches for survivors at risk of SPBC.  \nWith approximately 18.6 million cancer survivors currently living in the United States, a number expected to rise in the coming decades, there is a growing recognition of the long-term consequences of cancer survivorship, including the development of a second primary malignancy1. This risk is particularly relevant among younger cancer survivors, who have a longer post-treatment life expectancy and often receive intensive therapies such as chemotherapy2 and radiation3 for their primary malignancies. Studies of large cohorts of childhood cancer survivors reported a 4- to 6-fold increased risk of second primary malignancies compared to the general population4–7, with breast cancer being the most common8.  \nAs survival rates improve, understanding the clinical and molecular characteristics of second primary breast cancers (SPBCs) has become increasingly important9. Population-based studies have demonstrated that SPBCs are associated with worse overall and breast cancer-specific survival compared to age-matched patients with  \n1Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Carretera de Valldemossa 79, Palma, Illes Balears 07120, Spain. 2Providence Saint John’s Health Center, Saint John’s Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA. 3Jackson Memorial Hospital, University of Miami Miller School of Medicine, 1611 NW 12th Ave, Miami, FL 33136, USA. 4Department of Surgery, Duke University School of Medicine, 2301 Erwin Rd, Durham, NC 27707, USA. 5KOTAI Biotechnologies Inc., 3-4-17 Senba","cbCaiebCX44v12ac","https://ap.wps.com/l/cbCaiebCX44v12ac","pdf",4433447,14,"English","# Distinct epigenetic alterations and accelerated mitotic aging define second primary breast cancers\n## Study rationale and clinical context for SPBC\n## Genome-wide methylation profiling and integrated multi-omics validation\n## Epigenetic aging assessment with epiTOC\n## Key findings: prognosis, differential CpGs, endocrine signaling suppression\n## Implications for risk stratification and therapy for survivors","[{\"question\":\"What distinguishes SPBCs from FPBCs at the molecular level in this study?\",\"answer\":\"SPBC tumors show poorer prognosis and recurrent epigenetic “molecular scars,” including suppressed endocrine signaling and accelerated mitotic aging. The study identifies many differentially methylated CpG sites and altered methylation at transcription factor binding sites tied to aging and malignancy traits.\"},{\"question\":\"How were epigenetic alterations and aging measured in the research?\",\"answer\":\"DNA methylation profiling was used to detect differential CpG sites between SPBC and FPBC. Epigenetic aging was assessed using the mitotic clock epiTOC, while ENCODE chromatin immunoprecipitation sequencing data mapped changes at transcription factor binding sites.\"},{\"question\":\"What is the evidence that epigenetic changes relate to hormone signaling in SPBC?\",\"answer\":\"Transcriptomic analysis confirmed coordinated downregulation of hormone signaling pathways, including estrogen, progesterone, and androgen cascades. This aligns with promoter-level hypermethylation enriched in genes involved in morphogenesis, hormone signaling, and cell adhesion.\"}]","Distinct epigenetic alterations and accelerated mitotic aging define second primary breast cancers | PDF",1790083913,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77ad94972c7cf083123fc52943135752.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/671c227e95390d4c7ba18606c17cded0.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84f1798e61e6d6e7402eb1279bec1ab2.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7deab4accfbbf82528238337b057a716.webp",980,1287]